scispace - formally typeset
T

Takeki Hirano

Researcher at Boston Children's Hospital

Publications -  35
Citations -  682

Takeki Hirano is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Short stature & Growth hormone deficiency. The author has an hindex of 15, co-authored 35 publications receiving 655 citations.

Papers
More filters
Journal ArticleDOI

Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: Implications for the development of Turner syndrome

TL;DR: It is suggested that haploinsufficiency of SHOX causes not only short stature but also Turner skeletal anomalies (such as short 4th metacarpals, cubitus valgus, and LWD) and that growth pattern is primarily dependent on the presence or absence of LWD.
Journal ArticleDOI

Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan

TL;DR: It is concluded that the incidence of leukemia in GH-treated patients without risk factors is not greater than that in the general population aged 0-15 yr, and a possible increased occurrence of leukemia with GH treatment appears to be limited to patients with risk factors.
Journal ArticleDOI

Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.

TL;DR: Interrelationships among serum levels of insulin, IFG‐I, IGF binding protein (IGFBP)‐1 and ‐3 and growth hormone bindingprotein (GHBP) in prepubertal obese children are evaluated.
Journal ArticleDOI

Serum leptin and insulin concentrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children

TL;DR: To evaluate the relationship between serum levels of leptin and insulin in prepubertal lean, obese and insulin‐dependent diabetes mellitus (IDDM) children, a large number of children were diagnosed with either type of diabetes or both.
Journal ArticleDOI

Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus.

TL;DR: In this paper, the authors measured serum DPP4 activity and assessed its relationship to metabolic variables in T1DM children using a fluorometric assay in 43 Type 1 diabetes mellitus (T1DM) and 26 control children.